Banque Cantonale Vaudoise’s VanEck Biotech ETF BBH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292	Sell	1,437 -95	-6%	-$17.9K	﹤0.01%	595
2026 Q1	$288K	Hold	1,532	–	–	0.01%	581
2025 Q4	$290K	Hold	1,532	–	–	0.01%	530
2025 Q3	$254K	Buy	1,532 +326	+27%	+$53.2K	0.01%	535
2025 Q2	$185K	Buy	+1,206	New	+$180K	0.01%	552
2024 Q3	$55K	Hold	310	–	–	﹤0.01%	620
2024 Q2	$52K	Hold	310	–	–	﹤0.01%	788
2024 Q1	$52K	Hold	310	–	–	﹤0.01%	777
2023 Q4	$51K	Sell	310 -20	-6%	-$3.08K	﹤0.01%	798
2023 Q3	$51K	Hold	330	–	–	﹤0.01%	967
2023 Q2	$51K	Sell	330 -23	-7%	-$3.67K	﹤0.01%	961
2023 Q1	$57K	Buy	353 +15	+4%	+$2.43K	﹤0.01%	936
2022 Q4	$54K	Buy	+338	New	+$53.5K	﹤0.01%	945
2020 Q3	–	Sell	-840	Closed	-$137K	–	1054
2020 Q2	$137K	Buy	+840	New	+$128K	0.01%	733

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Banque Cantonale Vaudoise's BBH Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its VanEck Biotech ETF (BBH) stake by 6.2% in Q2 2026, selling an estimated $17.9K and leaving 1,437 shares worth $292. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Banque Cantonale Vaudoise first reported a position in BBH in Q2 2020 and has held it in 14 quarters since. The position peaked at $290K in Q4 2025. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Banque Cantonale Vaudoise held 1,437 shares of VanEck Biotech ETF worth $292 as of Q2 2026.
Banque Cantonale Vaudoise sold 95 VanEck Biotech ETF shares in Q2 2026, an estimated $17.9K.
VanEck Biotech ETF made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #595 holding.
Banque Cantonale Vaudoise first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 14 quarters since.
Banque Cantonale Vaudoise's VanEck Biotech ETF position peaked at $290K in Q4 2025.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.